Profusa (PFSA) Total Non-Current Liabilities (2021 - 2026)
Profusa (PFSA) posted quarterly Total Non-Current Liabilities of $17.6 million for Q1 2026, up 23.67% year-over-year from $14.3 million in Q1 2025, and down 2.53% quarter-over-quarter from $18.1 million in Q4 2025.
Profusa (PFSA) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Profusa's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $17.6 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 23.67% year-over-year to $17.6 million; the TTM figure through Mar 2026 stood at $17.6 million (up 23.67% YoY), while the FY2025 annual figure was $18.1 million, down 67.03% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $17.6 million, down from $18.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $54.9 million in Q4 2024, with the low at $85588.0 in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $5.0 million (2023), against an average of $9.5 million.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities tumbled 79.91% in 2022, then jumped 4619.15% in 2023.
- Profusa's Total Non-Current Liabilities stood at $1.4 million in 2022, then soared by 253.09% to $5.0 million in 2023, then surged by 992.3% to $54.9 million in 2024, then sank by 67.03% to $18.1 million in 2025, then dropped by 2.53% to $17.6 million in 2026.
- Business Quant data shows PFSA's Total Non-Current Liabilities at $17.6 million in Q1 2026, $18.1 million in Q4 2025, and $19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Profusa | 129,730.48 | -245,269.52 | - | 17.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.64 Mn |
| Dec 31, 2025 | 18.10 Mn |
| Sep 30, 2025 | 19.36 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 14.26 Mn |
| Dec 31, 2024 | 54.90 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 5.08 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Sep 30, 2023 | 3.37 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 4.04 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 400,282.00 |
| Jun 30, 2022 | 160,243.00 |
| Mar 31, 2022 | 85,588.00 |
| Dec 31, 2021 | 7.08 Mn |